NCT05004974 2024-03-12Sintilimab With Pemigatinib in Patients With PD-L1-positive and FGFR Mutated Advanced Non-small Cell Lung CancerThe Fourth Affiliated Hospital of Zhejiang University School of MedicinePhase 2 Unknown20 enrolled